(Funded by the U.S. National Science Foundation and the National Institutes of Health)
Researchers at the University of Pittsburgh have developed silk iron microparticles and magnetic iron oxide nanoparticles and then chemically bonded the silk microparticles with the nanoparticles. The microparticles were designed to deliver drugs to sites in the body, and the drugs were towed by the microparticles like a trailer is towed by a car. “You can think of it like towing cargo – we created the [micro]particles to carry drugs, and the nanoparticles are the tow hook,” said Mostafa Bedewy, associate professor at the University of Pittsburgh. Now that the researchers have found a way to magnetically guide the silk microparticles with the nanoparticles, the next step will be to load them with therapeutic cargo. This research opens the door to a wide range of future applications – from targeted cancer therapies to regenerative treatments for cardiovascular disease.

(Funded by the U.S. Department of Energy)
Researchers from the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California, Los Angeles, have created a heat pump that consists of stacked layers of electrocaloric materials, which temporarily change temperature in response to an electric field. Six polymer film discs, each about an inch in diameter and coated with carbon nanotubes, serve as a heat pump, moving warmth from the layer closest to the heat source away to the outermost layer. The nanotubes function as conductors for the electric field that stimulates the material. A proof of concept lowered ambient temperatures by 16 degrees Fahrenheit within 30 seconds, and readings at the edge of the device dipped as low as 25 degrees Fahrenheit.

(Funded by the U.S. Department of Energy)
Scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) and SLAC National Accelerator Laboratory have revealed the fundamental mechanisms that limit the performance of copper nanocatalysts – critical components in chemical reactions that transform carbon dioxide and water into valuable fuels and chemicals. Copper’s catalytic properties quickly degrade during these reactions, diminishing its performance over time. The researchers identified and observed two competing mechanisms that drive the copper nanoparticles that make up the nanocatalysts to the brink of degradation: nanoparticle migration and coalescence, in which smaller particles combine into larger ones, and Ostwald ripening, where larger particles grow at the expense of smaller particles. These findings suggest mitigation strategies to protect the copper nanocatalysts by limiting either mechanism. Part of the research was conducted at the Molecular Foundry, a DOE Office of Science national user facility at Berkeley Lab.

(Funded by the U.S. Department of Energy and the U.S. National Science Foundation)
For more than 100 years, scientists have used a method called crystallography to determine the atomic structure of materials, but this technique only works well when researchers have large, pure crystals. For a powder of nanocrystals, the method only hints at the unseen structure. Now, scientists at Columbia Engineering have created a machine learning algorithm that can observe the pattern produced by a powder of nanocrystals to infer their atomic structures. The scientists began with a dataset of 40,000 crystal structures and jumbled their atomic positions until they were indistinguishable from random placement. Then, they trained a deep neural network to connect these almost randomly placed nanocrystals with their associated X-ray diffraction patterns. Lastly, the algorithm was able to determine the atomic structure from nanocrystals of various shapes in the powder.

(Funded by the National Institutes of Health)
Historically, the vast majority of pharmaceutical drugs have been designed down to the atomic level, so that the specific location of each atom within the drug molecule determines how well it works and how safe it is. Now, Northwestern University and Mass General Brigham scientists argue that this precise structural control should be applied to optimize new nanomedicines. The scientists cite three examples of trailblazing structural nanomedicines: spherical nucleic acids (globular form of DNA that can easily enter cells and bind to targets), chemoflares (smart nanostructures that release chemotherapeutic drugs in response to cues in cancer cells) and megamolecules (precisely assembled protein structures that mimic antibodies).